By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > FDA Alert: Medline Issues Urgent Recall of Namic Star Off-Handle Manifolds Over Blood Clot Risk

FDA Alert: Medline Issues Urgent Recall of Namic Star Off-Handle Manifolds Over Blood Clot Risk

GMJ
Last updated: 27/05/2026 13:05
By
GMJ News Desk
Share
1 Min Read
SHARE
1 min read|164 words
🚨 Breaking Newsvia FDA Safety Alerts

The U.S. Food and Drug Administration (FDA) has issued a safety alert for Medline’s Namic Star off-handle manifolds following reports that particulate matter may enter blood circulation during use. The recalled medical devices carry the risk of particles becoming lodged in blood vessels, potentially causing serious vascular complications in patients.

The Namic Star manifold line is widely used in medical facilities for fluid administration and blood draw procedures. Healthcare providers and hospital systems currently using these devices should immediately cease use and review their existing inventory. The scope and number of affected units are being assessed by both Medline and the FDA.

The FDA is coordinating with Medline to implement a full product recall and conduct a root cause investigation into the particulate contamination issue. Healthcare facilities should report any adverse events or patient injuries related to these manifolds to the FDA MedWatch program. This is a developing story.

Source: Manifold Recall: Medline Removes Namic Star Off Handle Manifolds 

Submit Your Paper
GMJ_Submit_Banner

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Women’s Empowerment Programs in Poor Countries Lack Clear Measurement Standards

A comprehensive scoping review reveals significant gaps in how women's empowerment programs…

Brown Dog Tick Linked to Fatal SFTS Case with Multiorgan Failure in Thailand

Thai researchers document first confirmed case of SFTS virus transmission by brown…

New Antiviral Drug Shows Promise Against COVID-19 in Clinical Research

New research examines inosine pranobex, an established antiviral drug, as a potential…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Automated compounding system with syringe labels in hospital pharmacy setting

FDA Issues Class II Recall for Omnicell Syringe Labels Following System Detection Failures

By
GMJ News Desk
01/06/2026

🚨 🧠 SITUATION BRIEF: Ebola Outbreak – DRC/Uganda Border Region

By
GMJ News Desk
31/05/2026
Medical illustration showing optic nerve blood flow blockage causing sudden vision loss

Data Deep Dive: Why Wegovy’s Eye Stroke Risk Signal Exceeds Ozempic by 5-Fold

By
GMJ News Desk
07/06/2026

🚨 🧠 EBOLA OUTBREAK – DRC/UGANDA BORDER CROSSING WITH PHEIC DECLARATION

By
GMJ News Desk
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up